Trial Profile
Phase 1 Trial of Flavopiridol in Combination With Lenalidomide in Patients With Relapsed or Refractory B-Cell CLL/SLL
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Alvocidib
- Indications B-cell prolymphocytic leukaemia; Chronic lymphocytic leukaemia
- Focus Adverse reactions
- 07 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Mar 2013 Planned end date changed from 1 Jan 2100 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 18 Jul 2012 Planned End Date changed from 1 Jun 2010 to 1 Jan 2100 as reported by ClinicalTrials.gov.